Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-005408

Chief Operating Officer acquired 61,963 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stevens Christopher James Chief Operating Officer 2026-02-11 Grant or award +61,963 469,129 D
Derivatives
Stevens Christopher James Chief Operating Officer 2026-02-11 Grant or award · Stock Option (Right to Buy) +93,037 93,037 D
Loading xslF345X05/form4.xml…